Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE6D | O43924 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 9/20 | 0.35 |
| ▸ | PGR | P06401 | 6/20 | 0.33 |
| ▸ | TYMS | P04818 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 1/20 | 0.30 |
| ▸ | FAAH | O00519 | 1/20 | 0.30 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22183303 | 0.94 | PDK2 (0.36) | PDE6DPDK2PGRTYMSAR | |
| SCHEMBL22183353 | 0.93 | PDK2 (0.36) | PDE6DPDK2PGRTYMS | |
| SCHEMBL17816744 | 0.93 | PDE6D (0.38) | PDE6DPDK2PGRAR | |
| SCHEMBL19001901 | 0.91 | PDK2 (0.35) | PDE6DPDK2PGRTYMS | |
| SCHEMBL17197603 | 0.90 | PDE6D (0.38) | PDE6DPDK2PGRTYMS | |
| SCHEMBL15290070 | 0.89 | PDK2 (0.42) | PDE6DPDK2PGRFAAHMGLL | |
| SCHEMBL15183557 | 0.89 | PDK2 (0.42) | PDE6DPDK2PGRFAAHMGLL | |
| SCHEMBL25495747 | 0.88 | PDK2 (0.36) | PDE6DPDK2PGRTYMSAR | |
| SCHEMBL22183310 | 0.88 | PDK2 (0.37) | PDE6DPDK2PGR | |
| SCHEMBL25496108 | 0.88 | PDK2 (0.38) | PDE6DPDK2PGRARFAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11737354-B2 | Organic light emitting device having a carbazole-based compound formed between a cathode and a light emitting layer and a spirobifluorene-monoamine-based compound formed between an anode and a light emitting layer | LG CHEM, LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| US-11737354-B2 | Organic light emitting device having a carbazole-based compound formed between a cathode and a light emitting layer and a spirobifluorene-monoamine-based compound formed between an anode and a light emitting layer | LG CHEM, LTD. (KR) | 2023-08-22 | — | — | US | disclosed |
| US-20200295264-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2020-09-17 | — | — | US | disclosed |
| US-10714692-B2 | Organic light emitting device having a carbazole-based compound formed between cathode and light emitting layer and a spirobifluorene-monoamine based compound formed between anode and light emitting layer | LG CHEM, LTD. (KR) | 2020-07-14 | — | — | US | disclosed |
| US-20160225993-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2016-08-04 | — | — | US | disclosed |
| US-20160225993-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2016-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200295264-A1 | ORGANIC LIGHT EMITTING DEVICE | TPH1, DRD1, CYP1A1 | PDE6D 1540/4885PDK2 917/4885PGR 1268/4885 |
| US-10714692-B2 | Organic light emitting device having a carbazole-based compound formed between cathode and light emitting layer and a spirobifluorene-monoamine based compound formed between anode and light emitting layer | COMT, MAOB, MAOA | PDE6D 363/4885PDK2 227/4885PGR 967/4885 |
| US-11737354-B2 | Organic light emitting device having a carbazole-based compound formed between a cathode and a light emitting layer and a spirobifluorene-monoamine-based compound formed between an anode and a light emitting layer | DRD1, TPH1, DRD3 | PDE6D 1130/4885PDK2 358/4885PGR 1439/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.